TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW 24
1.4 CURRENCY AND PRICING 26
1.5 LIMITATIONS 26
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 DBMR TRIPOD DATA VALIDATION MODEL 32
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.6 MULTIVARIATE MODELLING 36
2.7 MARKET END USER COVERAGE GRID 37
2.8 PRODUCT LIFELINE CURVE 38
2.9 DBMR MARKET POSITION GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PORTER'S FIVE FORCES MODEL 46
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS 47
4.3 USE CASES 49
5 VALUE CHAIN ANALYSIS 50
6 EUROPE E-CLINICAL SOLUTIONS MARKET: REGULATIONS 51
7 MARKET OVERVIEW 57
7.1 DRIVERS 59
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS 59
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE 59
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 60
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES 60
7.2 RESTRAINTS 61
7.2.1 DATA SAFETY AND PRIVACY ISSUES 61
7.2.2 LACK OF SKILLED PROFESSIONALS 61
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES 62
7.3 OPPORTUNITIES 62
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS 62
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS 63
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS 63
7.4 CHALLENGES 64
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS 64
7.4.2 HIGH IMPLEMENTATION COSTS 64
8 EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT 66
8.1 OVERVIEW 67
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 70
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 71
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS 72
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS 73
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 74
8.7 SAFETY SOLUTIONS 75
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 76
8.9 CLINICAL DATA INTEGRATION PLATFORMS 77
8.10 CLINICAL ANALYTICS PLATFORMS 78
8.11 CARE COORDINATION MEDICAL RECORD (CCMR) 79
8.12 OTHERS 80
9 EUROPE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 82
9.1 OVERVIEW 83
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 86
9.3 CLOUD-BASED (SAAS) SOLUTIONS 86
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 87
10 EUROPE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 89
10.1 OVERVIEW 90
10.2 PHASE III 93
10.3 PHASE I 93
10.4 PHASE II 94
10.5 PHASE IV 95
11 EUROPE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE 96
11.1 OVERVIEW 97
11.2 MEDIUM AND SMALL 100
11.3 LARGE 101
12 EUROPE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE 102
12.1 OVERVIEW 103
12.2 DESKTOP 106
12.3 TABLET 106
12.4 SMART PHONE 107
12.5 HANDHELD PDA DEVICE 108
12.6 OTHERS 108
13 EUROPE E-CLINICAL SOLUTIONS MARKET, BY END USER 110
13.1 OVERVIEW 111
13.2 CONTRACT RESEARCH ORGANIZATIONS 114
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 114
13.4 MEDICAL DEVICE MANUFACTURERS 115
13.5 HOSPITAL 116
13.6 CONSULTING SERVICE COMPANIES 116
13.7 ACADEMIC RESEARCH INSTITUTES 117
14 EUROPE E-CLINICAL SOLUTIONS MARKET, BY REGION 118
14.1 EUROPE 119
14.1.1 GERMANY 127
14.1.2 FRANCE 130
14.1.3 U.K. 133
14.1.4 ITALY 136
14.1.5 SPAIN 139
14.1.6 RUSSIA 142
14.1.7 TURKEY 145
14.1.8 NETHERLANDS 148
14.1.9 BELGIUM 151
14.1.10 SWITZERLAND 154
14.1.11 REST OF EUROPE 157
15 EUROPE E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 158
15.1 COMPANY SHARE ANALYSIS: EUROPE 158
16 SWOT ANALYSIS 159
17 COMPANY PROFILE 160
17.1 ORACLE 160
17.1.1 COMPANY SNAPSHOT 160
17.1.2 REVENUE ANALYSIS 160
17.1.3 COMPANY SHARE ANALYSIS 161
17.1.4 PRODUCT PORTFOLIO 161
17.1.5 RECENT DEVELOPMENT 161
17.2 DASSAULT SYSTEMES 162
17.2.1 COMPANY SNAPSHOT 162
17.2.2 REVENUE ANALYSIS 162
17.2.3 COMPANY SHARE ANALYSIS 163
17.2.4 PRODUCT PORTFOLIO 163
17.2.5 RECENT DEVELOPMENTS 164
17.3 CLARIO 165
17.3.1 COMPANY SNAPSHOT 165
17.3.2 COMPANY SHARE ANALYSIS 165
17.3.3 PRODUCT PORTFOLIO 166
17.3.4 RECENT DEVELOPMENT 166
17.4 VEEVA SYSTEMS 167
17.4.1 COMPANY SNAPSHOT 167
17.4.2 REVENUE ANALYSIS 167
17.4.3 COMPANY SHARE ANALYSIS 168
17.4.4 PRODUCT PORTFOLIO 168
17.4.5 RECENT DEVELOPMENTS 169
17.5 ARISEUROPE 170
17.5.1 COMPANY SNAPSHOT 170
17.5.2 COMPANY SHARE ANALYSIS 170
17.5.3 PRODUCT PORTFOLIO 171
17.5.4 RECENT DEVELOPMENTS 171
17.6 4G CLINICAL 172
17.6.1 COMPANY SNAPSHOT 172
17.6.2 PRODUCT PORTFOLIO 172
17.6.3 RECENT DEVELOPMENT 172
17.7 ADVARRA. 173
17.7.1 COMPANY SNAPSHOT 173
17.7.2 PRODUCT PORTFOLIO 173
17.7.3 RECENT DEVELOPMENT 173
17.8 ANJU 174
17.8.1 COMPANY SNAPSHOT 174
17.8.2 PRODUCT PORTFOLIO 174
17.8.3 RECENT DEVELOPMENTS 175
17.9 CASTOR. 176
17.9.1 COMPANY SNAPSHOT 176
17.9.2 PRODUCT PORTFOLIO 176
17.9.3 RECENT DEVELOPMENTS 176
17.10 DATATRAK INT. 177
17.10.1 COMPANY SNAPSHOT 177
17.10.2 PRODUCT PORTFOLIO 177
17.10.3 RECENT DEVELOPMENT 177
17.11 ECLINICAL SOLUTIONS LLC. 178
17.11.1 COMPANY SNAPSHOT 178
17.11.2 PRODUCT PORTFOLIO 178
17.11.3 RECENT DEVELOPMENT 178
17.12 IQVIA INC 179
17.12.1 COMPANY SNAPSHOT 179
17.12.2 REVENUE ANALYSIS 179
17.12.3 PRODUCT PORTFOLIO 180
17.12.4 RECENT DEVELOPMENTS 180
17.13 MAXISIT 181
17.13.1 COMPANY SNAPSHOT 181
17.13.2 PRODUCT PORTFOLIO 181
17.13.3 RECENT DEVELOPMENT 182
17.14 MEDNET 183
17.14.1 COMPANY SNAPSHOT 183
17.14.2 PRODUCT PORTFOLIO 183
17.14.3 RECENT DEVELOPMENT 184
17.15 MEDRIO, INC. 185
17.15.1 COMPANY SNAPSHOT 185
17.15.2 PRODUCT PORTFOLIO 185
17.15.3 RECENT DEVELOPMENTS 186
17.16 MERATIVE 187
17.16.1 COMPANY SNAPSHOT 187
17.16.2 PRODUCT PORTFOLIO 187
17.16.3 RECENT DEVELOPMENT 187
17.17 OPENCLINICA, LLC 188
17.17.1 COMPANY SNAPSHOT 188
17.17.2 PRODUCT PORTFOLIO 188
17.17.3 RECENT DEVELOPMENT 188
17.18 PAREXEL INTERNATIONAL CORPORATION 189
17.18.1 COMPANY SNAPSHOT 189
17.18.2 PRODUCT PORTFOLIO 189
17.18.3 RECENT DEVELOPMENT 189
17.19 QURETEC 190
17.19.1 COMPANY SNAPSHOT 190
17.19.2 PRODUCT PORTFOLIO 190
17.19.3 RECENT DEVELOPMENT 190
17.20 REALTIME SOFTWARE SOLUTIONS, LLC 191
17.20.1 COMPANY SNAPSHOT 191
17.20.2 PRODUCT PORTFOLIO 191
17.20.3 RECENT DEVELOPMENT 191
17.21 RESEARCH MANAGER 192
17.21.1 COMPANY SNAPSHOT 192
17.21.2 PRODUCT PORTFOLIO 192
17.21.3 RECENT DEVELOPMENT 192
17.22 SAAMA TECHNOLOGIES, LLC 193
17.22.1 COMPANY SNAPSHOT 193
17.22.2 PRODUCT PORTFOLIO 193
17.22.3 RECENT DEVELOPMENT 193
17.23 SIGNANT HEALTH 194
17.23.1 COMPANY SNAPSHOT 194
17.23.2 PRODUCT PORTFOLIO 194
17.23.3 RECENT DEVELOPMENT 194
17.24 Y-PRIME, LLC. 195
17.24.1 COMPANY SNAPSHOT 195
17.24.2 PRODUCT PORTFOLIO 195
17.24.3 RECENT DEVELOPMENT 195
18 QUESTIONNAIRE 196
19 RELATED REPORTS 199

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.